Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03390296
Title Pfizer Immunotherapy Combinations for Acute Myeloid Leukemia (AML) Multi-Arm Study 1
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

acute myeloid leukemia


Avelumab + Azacitidine + PF-04518600

Azacitidine + PF-04518600

Avelumab + Utomilumab

Avelumab + Glasdegib

Gemtuzumab ozogamicin + Glasdegib


Avelumab + PF-04518600

PF-04518600 + Utomilumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field